The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications for NIH Countermeasures Against Chemical Threats (CounterACT) exploratory/developmental (R21) projects. The mission of the NIH CounterACT program is to foster and support research that will advance development of new and improved therapeutics to mitigate the health effects of chemical threats. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pesticides, and pharmaceutical-based agents. Projects supported by this FOA are expected to generate preliminary data that would facilitate the development of competitive applications for more extensive support from theNIH CounterACT Cooperative Agreement programsor other related initiatives.
PAR-19-039 -U01Research Project – Cooperative Agreements
- Letter of Intent Due Date: 30 days before the application due date
- Application Due Date(s): May 26, 2021; May 31, 2022; May 30, 2023
PAR-20-253 Expiration Date May 31, 2023
The budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.